Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between tooth agenesis and cancer: a systematic review. | J Appl Oral Sci | 2021 | 34378652 | PubTator, text mining | PubMed |
| Effects of Genetic Variation on Endurance Performance, Muscle Strength, and Injury Susceptibility in Sports: A Systematic Review. | Front Physiol | 2021 | 34366884 | PubTator, text mining | PubMed |
| Potential Energy Surfaces of Vinylogous Wolff Rearrangement: NBO Analysis and Molecular Dynamic Simulation. | ChemistryOpen | 2021 | 34363326 | PubTator, text mining | PubMed |
| Haploinsufficiency of SF3B2 causes craniofacial microsomia. | Nat Commun | 2021 | 34344887 | PubTator, text mining | PubMed |
| Adult pancreatoblastoma: Current concepts in pathology. | World J Gastroenterol | 2021 | 34326617 | PubTator, text mining | PubMed |
| FGF gene family characterization provides insights into its adaptive evolution in Carnivora. | Ecol Evol | 2021 | 34306666 | PubTator, text mining | PubMed |
| FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors. | Biochim Biophys Acta Rev Cancer | 2021 | 34303787 | PubTator, text mining | PubMed |
| Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism. | J Clin Med | 2021 | 34300255 | PubTator, text mining | PubMed |
| The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer. | Cancers (Basel) | 2021 | 34298648 | PubTator, text mining | PubMed |
| Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations. | Transl Lung Cancer Res | 2021 | 34295690 | PubTator, text mining | PubMed |
| Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis. | Nat Commun | 2021 | 34294701 | PubTator, text mining | PubMed |
| Exome sequencing identifies novel somatic variants in African American esophageal squamous cell carcinoma. | Sci Rep | 2021 | 34285259 | PubTator, text mining | PubMed |
| Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models. | Genome Med | 2021 | 34271981 | PubTator, text mining | PubMed |
| Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma. | Cancer Sci | 2021 | 34263978 | PubTator, text mining | PubMed |
| Targeted therapy in SDH-deficient GIST. | Ther Adv Med Oncol | 2021 | 34262616 | PubTator, text mining | PubMed |
| Expression and Clinical Value of LncRNA GAPLINC in Esophageal Squamous Cell Carcinoma. | Onco Targets Ther | 2021 | 34262290 | PubTator, text mining | PubMed |
| Single gene variants causing deafness in Asian Indians. | J Genet | 2021 | 34238775 | PubTator, text mining | PubMed |
| FGF, Mechanism of Action, Role in Parkinson's Disease, and Therapeutics. | Front Pharmacol | 2021 | 34234672 | PubTator, text mining | PubMed |
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low-, intermediate-1-, intermediate-2-, and high-risk myelofibrosis in JUMP, a Phase 3b, expanded-access study. | Hematol Oncol | 2021 | 34224180 | PubTator, text mining | PubMed |
| Prior Therapy With Pegylated-Interferon Alfa-2b Improves the Efficacy of Adjuvant Pembrolizumab in Resectable Advanced Melanoma. | Front Oncol | 2021 | 34221994 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=31